Breast cancer trial patient participants younger than ever: Phesi
The company’s analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.
Headlines
Global Industry News
-
EU sets out intention to terminate COVID-19 vaccine deal with Valneva
from BioPharma-Reporter.com
-
Lonza secures deal with ALSA Ventures to support its portfolio of biotechs
from BioPharma-Reporter.com
-
Survey puts spotlight on US neurologists’ response to CMS Alzheimer drugs decision
from BioPharma-Reporter.com
-
Gerresheimer ramps up glass and plastic production capacities in India
from BioPharma-Reporter.com
Hot Topics
-
Reify Health funnels $220m into trial diversity effort
Patient centricity
-
AstraZeneca metastatic breast cancer treatment secures FDA approval
Patient centricity
-
Charles River, Valo join on AI-enabled drug discovery offering
Consolidation
-
FDA outlines benefit-risk approach to drug or biologic product quality assessment
Patient centricity
